Akebia Therapeutics, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $187.3m $70.2m $104.6m $147.4m $228.7m $149.8m $42.9m $51.9m $184.8m
Prepaid Expense and Other Assets, Current $2.2m $6.3m $15.7m $6.6m $14.9m $33.1m $33.5m $20.2m $11.3m $5.5m
Cash, Cash Equivalents, and Short-term Investments $260.4m $317.8m $321.6m $147.7m $268.7m $149.8m
Inventory, Net $114.2m $116.3m $61.0m $38.2m $41.1m $15.7m $16.2m $15.6m
Assets, Current $296.3m $358.4m $468.3m $309.5m $371.4m $272.0m $305.1m $118.1m $113.8m $253.0m
Property, Plant and Equipment, Net $2.6m $3.6m $8.0m $10.4m $8.6m $6.8m $5.2m $3.6m $2.2m $1.2m
Goodwill $55.1m $55.1m $55.1m $55.1m $59.0m $59.0m $59.0m $59.0m
Intangible Assets, Net (Excluding Goodwill) $36.0m $0
Operating Lease, Right-of-Use Asset $29.0m $26.9m $33.9m $12.4m $8.2m $3.7m
Other Assets, Noncurrent $1.3m $2.3m $137.0m $76.0m $38.0m $49.8m $12.4m $37.4m $59.7m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $34.2m $16.7m $38.9m $26.9m $50.9m $65.4m $39.3m $34.4m $47.0m
Accrued Liabilities, Current $30.3m $52.4m $150.9m $129.1m $130.6m $104.5m $114.2m $67.7m $63.5m $121.7m
Assets $300.2m $364.2m $996.5m $771.2m $644.1m $525.5m $541.8m $241.7m $220.7m $376.6m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $5.0m $5.3m $4.8m $4.5m $5.4m $3.5m
Accounts Payable, Current $2.0m $7.0m $42.8m $39.2m $41.3m $33.6m $18.0m $14.6m $15.2m $21.2m
Operating Lease, Liability, Noncurrent $27.5m $24.6m $33.7m $8.9m $3.5m $0
Deferred Revenue, Current $82.0m $84.9m $57.0m $39.8m $15.2m $20.9m $3.7m $0 $0 $2.7m
Deferred Revenue, Noncurrent $115.3m $98.0m $57.0m $39.8m $15.2m $20.9m $3.7m $0 $0 $2.7m
Long-term Debt, Excluding Current Maturities $75.8m $96.4m $0 $17.2m $38.7m $48.2m
Long-term Debt, Current Maturities $97.5m $17.5m $0
Liabilities, Current $114.3m $144.3m $265.7m $208.1m $187.1m $256.5m $258.5m $99.9m $80.9m $162.9m
Other Liabilities, Noncurrent $27k $22k $29.6m $30.2m $60.6m $82.5m $83.1m $8.9m $4.7m $1.8m
Deferred Tax Liabilities, Net $6.6m $0 $0 $0 $0 $0 $0
Liabilities $232.1m $244.9m $360.6m $376.4m $396.5m $449.1m $519.2m $272.3m $269.9m $344.0m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $0 $0 $1k $1k $1k $1k $2k $2k $2k $2k
Retained Earnings (Accumulated Deficit) ($297.1m) ($374.1m) ($514.4m) ($794.1m) ($1.2b) ($1.5b) ($1.5b) ($1.6b) ($1.7b) ($1.7b)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($42k) ($442k) ($261k) $0 $13k $6k $6k $6k $6k $6k
Additional Paid in Capital, Common Stock $365.3m $493.8m $1.2b $1.2b $1.4b $1.5b $1.6b $1.6b $1.7b
Stockholders' Equity Attributable to Parent $68.1m $119.3m $635.9m $394.8m $247.6m $76.5m ($30.6m) ($49.2m) $32.6m
Liabilities and Equity $300.2m $364.2m $996.5m $771.2m $644.1m $525.5m $541.8m $241.7m $220.7m $376.6m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.